(Q36283419)

13 August 2017

1 reference

title

Anti-SSA/Ro and anti-SSB/La antibody-mediated congenital heart block (English)

1 reference

13 August 2017

0 references

0 references

3

Z Amoura

1 reference

PubMed ID

16218462

Nathalie Costedoat-Chalumeau

13 August 2017

series ordinal

1

object named as

N Costedoat-Chalumeau

1 reference

13 August 2017

4

J C Piette

1 reference

PubMed ID

16218462

13 August 2017

Sophie Georgin-Lavialle

series ordinal

2

object named as

S Georgin-Lavialle

1 reference

13 August 2017

1 January 2005

1 reference

13 August 2017

1 reference

13 August 2017

14

1 reference

13 August 2017

9

1 reference

13 August 2017

660-664

1 reference

Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry

13 August 2017

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2195OA

Short- and long-term outcome of children with congenital complete heart block diagnosed in utero or as a newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2195OA

Cutaneous manifestations of neonatal lupus without heart block: characteristics of mothers and children enrolled in a national registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2195OA

Hepatobiliary disease in neonatal lupus: prevalence and clinical characteristics in cases enrolled in a national registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2195OA

Long-term outcome of mothers of children with complete congenital heart block

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2195OA

Long-term outcome of mothers of children with isolated heart block in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2195OA

Autoantibody-associated congenital heart block: TGFbeta and the road to scar

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2195OA

Cytokine polymorphisms and histologic expression in autopsy studies: contribution of TNF-alpha and TGF-beta 1 to the pathogenesis of autoimmune-associated congenital heart block

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2195OA

Transdifferentiation of cardiac fibroblasts, a fetal factor in anti-SSA/Ro-SSB/La antibody-mediated congenital heart block

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2195OA

Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage/fibroblast crosstalk in the pathologic cascade leading to congenital heart block

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2195OA

Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2195OA

Perinatal outcome of fetal complete atrioventricular block: a multicenter experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2195OA

Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2195OA

Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2195OA

Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2195OA

Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2195OA

Maternal autoantibodies and congenital heart block: mediators, markers, and therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2195OA

Neurotoxic effects of fluorinated glucocorticoid preparations on the developing mouse brain: role of preservatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2195OA

Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2195OA

Cushing's disease and pregnancy: report of six cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2195OA

Anti-SSA/Ro antibodies and the heart: more than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2195OA

Antenatal Glucocorticoid Treatment and Cystic Periventricular Leukomalacia in Very Premature Infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2195OA

10.1191/0961203305LU2195OA

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16218462